MRA Advisory Group Invests $1.74 Million in Astera Labs, Inc. $ALAB

MRA Advisory Group acquired a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the second quarter, HoldingsChannel reports. The firm acquired 3,594 shares of the company’s stock, valued at approximately $1,736,000.

Other institutional investors have also added to or reduced their stakes in the company. Royal Bank of Canada boosted its stake in Astera Labs by 167.3% in the 1st quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock worth $9,097,000 after purchasing an additional 95,409 shares during the period. AQR Capital Management LLC increased its holdings in Astera Labs by 213.4% during the 1st quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock worth $680,000 after purchasing an additional 7,756 shares in the last quarter. Empowered Funds LLC raised its stake in shares of Astera Labs by 917.3% in the 1st quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock valued at $277,000 after purchasing an additional 4,183 shares during the period. First Trust Advisors LP grew its holdings in shares of Astera Labs by 102.0% during the second quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock worth $10,196,000 after buying an additional 56,952 shares in the last quarter. Finally, Brown Advisory Inc. lifted its stake in Astera Labs by 54.9% in the 2nd quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock valued at $505,000 after acquiring an additional 1,977 shares in the last quarter. 60.47% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, General Counsel Philip Mazzara sold 14,076 shares of Astera Labs stock in a transaction on Monday, May 18th. The stock was sold at an average price of $231.78, for a total value of $3,262,535.28. Following the transaction, the general counsel owned 104,139 shares in the company, valued at approximately $24,137,337.42. This trade represents a 11.91% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Jack R. Lazar sold 10,000 shares of Astera Labs stock in a transaction on Thursday, June 4th. The shares were sold at an average price of $355.17, for a total value of $3,551,700.00. Following the completion of the transaction, the director owned 75,688 shares in the company, valued at approximately $26,882,106.96. The trade was a 11.67% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,244,395 shares of company stock valued at $358,865,571 over the last three months. 10.40% of the stock is owned by corporate insiders.

Astera Labs Stock Up 0.8%

Shares of Astera Labs stock opened at $334.17 on Friday. Astera Labs, Inc. has a 12-month low of $97.89 and a 12-month high of $499.48. The company has a market capitalization of $57.98 billion, a price-to-earnings ratio of 165.43, a PEG ratio of 3.84 and a beta of 3.84. The firm’s 50-day moving average price is $360.45 and its two-hundred day moving average price is $235.27.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating the consensus estimate of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company had revenue of $392.40 million during the quarter, compared to analysts’ expectations of $360.85 million. During the same period in the previous year, the company earned $0.44 EPS. The business’s revenue for the quarter was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, sell-side analysts expect that Astera Labs, Inc. will post 1.86 earnings per share for the current year.

Analysts Set New Price Targets

A number of analysts have recently issued reports on ALAB shares. Royal Bank Of Canada lifted their price objective on shares of Astera Labs from $425.00 to $500.00 and gave the company an “outperform” rating in a report on Wednesday. Jefferies Financial Group raised their target price on shares of Astera Labs from $270.00 to $450.00 and gave the company a “buy” rating in a research report on Wednesday. TD Cowen lowered their price target on Astera Labs from $425.00 to $375.00 and set a “hold” rating on the stock in a research report on Wednesday. Bank of America upped their target price on shares of Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a report on Tuesday, June 23rd. Finally, Evercore restated an “outperform” rating and issued a $297.00 price target on shares of Astera Labs in a research note on Tuesday, May 19th. Thirteen investment analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $325.25.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.